You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Brazil

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health continues to show double-digit growth

Consumer health continued to show a strong performance in 2011, driven by growing disposable incomes, mainly amongst the lower-income segments, which increased expenditure on such products to solve minor ailments. Sales showed that the market was not negatively impacted after ANVISA ruled that sales of OTC products and vitamins should be moved behind-the-counter so consumers had to ask for assistance from staff.

Back to basics: non-prescription drugs are expected to return to OTC status

A couple of years after ruling that non-prescription drugs were not to be sold over-the-counter, ANVISA is re-evaluating its position. Pharmaceutical companies and retailers contend that the possibility of bringing non-prescription drugs back to over-the-counter commercialisation cannot be ruled out.

Acquisitions are expected to continue as market growth attracts investors

Foreign investors continue to look to the Brazilian market for growth opportunities. Company activity is expected to continue, primarily through the purchase of smaller domestic companies. Besides acquisitions, joint ventures and partnerships are also contributing to the changing competitive environment in Brazil.

Mergers and acquisitions in parapharmacies/drugstores

Parapharmacies/drugstores remained the most important channel for sales of OTC products and vitamins and dietary supplements due to Law 5991, approved on 17 December 1976, which restricts the distribution of medicines (prescription and non-prescription) to these outlets. The potential growth of the pharmaceuticals market in Brazil has attracted the investment of chained parapharmacies/drugstores in mergers and acquisitions. In 2011 Droga Raia and Drogasil merged to become Raia Drogasil, and it became one of the leading players. Pague Menos merged with Ultrafarma, a strong player in internet retailing, and Brazil Pharma, an investment fund, acquired several parapharmacies/drugstores in different areas of Brazil to compete against Drogaria São Paulo and Raia Drogasil.

A domestic pharmaceutical company is created to produce biotechnological drugs

In the forecast five years consumer health is expected to maintain a similar growth rate to that experienced over the review period. This will be a result of improvements in purchasing power, which will guarantee further access of lower-income consumers to medicines, and the ageing population, which will demand medicines to prevent and treat diseases related to age, such as osteoporosis, cardiovascular disease and arthritis.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Brazil with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Brazil for free:

The Consumer Health in Brazil market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Brazil?
  • What are the major brands in Brazil?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Brazil - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to show double-digit growth

Back to basics: non-prescription drugs are expected to return to OTC status

Acquisitions are expected to continue as market growth attracts investors

Mergers and acquisitions in parapharmacies/drugstores

A domestic pharmaceutical company is created to produce biotechnological drugs

KEY TRENDS AND DEVELOPMENTS

ANVISA is expected to change the rules for sales of non-prescription drugs

Vitamins and dietary supplements suffers from deficient regulation

Price control tools keep adjustments below inflation, but are not sufficient

Market growth drives company activity

Domestic companies join forces to produce biotechnological remedies

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

De-reimbursement

Generics

Advertising

Packaging and Labelling

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Brazil - Company Profiles

Aché Laboratórios Farmacêuticos SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Aché Laboratórios Farmacêuticos SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 5 Aché Laboratórios Farmacêuticos SA: Competitive Position 2011

Bayer (Brasil) SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Bayer (Brasil) SA: Competitive Position 2011

Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2011

Cadbury Adams Brasil Indústria e Comércio de Produtos Alimentícios Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Competitive Position 2011

EMS SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 16 EMS SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 17 EMS SA: Competitive Position 2011

Eurofarma Laboratório Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 20 Eurofarma Laboratório Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 21 Eurofarma Laboratório Ltda: Competitive Position 2011

Hypermarcas SA in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 24 Hypermarcas SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 25 Hypermarcas SA: Competitive Position 2011

Medley SA Indústria Farmacêutica in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 28 Medley SA Indústria Farmacêutica: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 29 Medley SA Indústria Farmacêutica: Competitive Position 2011

Nycomed Pharma Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 32 Nycomed Pharma Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 33 Nycomed Pharma Ltda: Competitive Position 2011

Sanofi-Aventis Farmacêutica Ltda in Consumer Health (Brazil)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 36 Sanofi-Aventis Farmacêutica Ltda: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 37 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2011

Adult Mouth Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • Sales of OTC adult mouth care products are restricted by regulations which require a medical prescription for the commercialisation of items containing active ingredients based on and/or derived from cortisone. As such, OTC adult mouth care products face strong competition from prescription drugs. In addition, home remedies such as gargling and rinsing the mouth with mixtures containing water and sodium bicarbonate are quite popular.

SWITCHES

COMPETITIVE LANDSCAPE

  • Peroxyl leads sales within adult mouth care with 27% value share. The performance of the product is a result of investment in visiting dentists, who are the mainly responsible for prescribing this type of products. Malvona and Albicon have long tradition in the Brazilian market and remained ranked third and forth, respectively, with steady market share.

PROSPECTS

  • Adult mouth care is expected to present a modest constant value CAGR of -2% over the forecast period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Brazil - Category Analysis

HEADLINES

TRENDS

  • Sales of OTC analgesics increased by 13% in current value terms in 2011. Double-digit growth was stimulated in the last few years by a growing number of Brazilians leaving the low-income segment, and able to join the middle-classes. Between 2006 and 2011 analgesics presented CAGR of 13% current value terms. According to a survey by Data Folha, one out of six Brazilians can be characterised as middle-class. Several factors contributed to the higher consumption of analgesics amongst the middle-classes. First, improved economic conditions translated into more discretionary income, which in turn allowed for the purchase of products which help to relieve pain, as well as alleviating uncomfortable symptoms. Secondly, consumers became better informed about product characteristics through the media and advertising. Last but not least, a significant number of those who reached the middle-classes were women.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis Farmacêutica led analgesics in 2011 with a 23% value share. Dorflex from Sanofi-Aventis was the leading brand with a 15% value share.

PROSPECTS

  • Analgesics is expected to post a constant value CAGR of 6% during the forecast period. An increase in discretionary income amongst less affluent consumer groups is expected to continue to drive growth. Young middle-class women stimulated growth in recent years, and are likely to continue to do so. As more young women join the labour force, enter universities and start their own families, higher demand is expected for analgesics to relieve the headaches and general pains caused by stressful routines.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Brazil - Category Analysis

HEADLINES

TRENDS

  • According to Associação Brasileira do Sono (Brazilian Sleep Association), 43% of the Brazilian population reports some degree of insomnia and other sleep disorders. ANVISA (Brazilian Health Surveillance Agency) reports that between 2007 and 2010 calming and sleeping controlled medication (Rx drugs) with active ingredients clonazepam, bromazepan and alprazolam featured amongst the top-selling drugs commercialised in Brazil. This is to say that a significant number of Brazilians suffer from insomnia and look for ways to end their sleepless nights. However, sales of prescription drugs strongly compete with OTC calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pasalix from Marjan Indústria e Comércio led calming and sleeping with a 25% value share in 2011. Marjan Indústria e Comércio and Produtos Farmacêuticos Millet Roux dominate sales. Both companies effectively promote their brands to doctors, rather than focusing directly on retailers and/or individual consumers.

PROSPECTS

  • Calming and sleeping is expected to post a constant value CAGR of 3% during the forecast period. In spite of the growing number of people suffering from anxiety and insomnia, sales growth is expected to follow a quite modest path as a result of competition from prescription calming and sleeping products.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil - Category Analysis

HEADLINES

TRENDS

  • Higher income levels amongst the poorer segments of society drove sales of cough, cold and allergy (hay fever) remedies in Brazil in 2011. Not only did higher incomes mean more discretionary income to spend on healthcare, but also improved economic conditions allowed less privileged consumer groups to gain access to healthcare providers, as well as to gain more information about the medicines available and product characteristics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated confectionery accounted for a 31% share of overall value sales of cough, cold and allergy (hay fever) remedies in Brazil in 2011. Manufacturers tend to target young consumer groups, positioning their brands as flavoursome, refreshing and able to alleviate the minor discomforts of colds and coughs. Cadbury Adams Brasil Indústria e Comércio de Produtos Alimentícios led cough, cold and allergy (hay fever) remedies in 2011 with a 12% value share with the brand Halls, which accounted for a 10% value share. Its lead can be attributed to the wide presence of Halls in mass media channels, as well as in social media networks. Targeting young consumer groups, Halls invests in sweepstakes and digital campaigns. In 2011 30% of the brand’s marketing budget was allocated to the campaign for Halls Mel Mix, which positions the brand as flavoursome and refreshing. Besides Halls, other brands of medicated confectionery, such as Icekiss and Freegells, enjoy popularity, with each brand holding a 3% value share in 2011.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to see a CAGR of 5% in constant value terms during the forecast period. Rising living standards will contribute to higher sales of such products. Improved economic conditions are expected to continue, allowing the lower-income urban populations to purchase cold and cough remedies which help to alleviate the respiratory problems caused by pollution and viral contamination. Higher employment will continue to expose a larger number of individuals, who use public transportation, to the propagation of cold and flu viruses.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Brazil - Category Analysis

HEADLINES

TRENDS

  • Higher living standards are contributing to increasing sales of digestive remedies. On the one hand, this definitely comes as good news, given that it indicates that more people are able to purchase products to alleviate their digestive problems. On the other hand, however, higher living standards may also be the very source of digestive ailments. More discretionary income means more eating out and more drinking, which can both affect digestive health. According to Euromonitor International, for example, fast food sales increased by 85% between 2006 and 2011. Moreover, improved economic conditions do not only lead to more jobs, but also more working hours and stress, which may also affect digestive health.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Brasil and Boehringer Ingelheim do Brasil Química e Farmacêutica held the leading two positions in digestive remedies in 2011, with 16% and 15% value shares respectively.

PROSPECTS

  • Digestive remedies is expected to see a constant value CAGR of 5% in the forecast period. Economic conditions, combined with dietary trends, will continue to drive sales during the coming years. Stress-related digestive ailments are also expected to continue to be a factor during the forecast period.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • ANVISA (Brazilian Health Surveillance Agency) allows a limited set of ear care products to be commercialised OTC. Consequently, sales are limited to products designed to alleviate minor discomfort, which result from a build-up of ear wax or fluid accumulation.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cerumin, from Alcon Laboratórios do Brasil, led ear care with a 51% value share in 2011. The brand enjoys high awareness amongst consumers. In addition, Alcon Laboratórios is able to maintain high penetration in parapharmacies/drugstores.

PROSPECTS

  • Ear care is expected to see a modest constant value CAGR of 1% over the forecast period 2011-2016. There are no indications that the status quo for OTC ear care products will witness a change in regulations during the forecast period. As such, most ear care products are likely to continue to be commercialised as prescription drugs.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • Brazilians seek eye comfort through the use of OTC eye care products as a result of several environmental factors. Ophthalmologists warn about the increasing adoption of eye care products without medical orientation, which hinders sales of non-prescription eye care products, in a bid to encourage patients to seek the assistance of a doctor.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon Laboratórios do Brasil led eye care with a 45% value share in 2011, as a result of the position of the company’s brands Lacrima and Claril. Alcon offers a relatively low-priced product line for minor eye discomfort. Both Lacrima and Claril enjoy high penetration rates in parapharmacies/drugstores, and are purchased by those seeking relief from minor itching, dryness and eye redness.

PROSPECTS

  • Eye care is expected to see a constant value CAGR of 5% during the forecast period. In spite of healthcare specialists warning about excessive use of OTC eye care products, sales are not expected to be significantly affected by such admonitions.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2006-2011
  • Table 53 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 54 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 55 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 56 Eye Care Company Shares by Value 2007-2011
  • Table 57 Eye Care Brand Shares by Value 2008-2011
  • Table 58 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Brazil - Category Analysis

HEADLINES

TRENDS

  • Increasing concern about general wellbeing, combined with demand for less aggressive medication, contributed to the expansion of herbal/traditional products in Brazil in 2011. The lack of clear regulation for the category restricted the expansion of herbal/traditional products in previous years. During the review period, however, advances in regulation provided an optimistic scenario to stimulate further growth. After new rules for bulas (information provided about the product inside the packaging) were introduced in early 2010, at the end of 2011 ANVISA (Brazilian Health Surveillance Agency) introduced the first edition of the National Herbal Formulary (Formulário Nacional de Fitoterápicos), which presents guidelines for the production of many herbal products, including creams, gels, dyes and syrups, amongst others. The new publication is part of Farmacopeia Brasileira (Brazilian Pharmacopoeia), which in turn defines the required standards for all medication produced in the country. The new publication is perceived as a positive development, because it represents the commitment of the authorities to providing a clear set of rules and procedures for the production and sale of herbal products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratório Canone led herbal/traditional products with an 18% value share in 2011. The company’s leading product, Valda, is a traditional brand which has been available in Brazil since the early 1900s. Valda enjoys high brand awareness and extensive market penetration in parapharmacies/drugstores. The brand has been successful in keeping up with market dynamics, with the expansion of its product line to include, for example, Valda Fibra (with Fibre) and Valda Organica, with herbs originating in the Amazon, besides different packaging designs and sizes.

PROSPECTS

  • Herbal/traditional products is expected to see a constant value CAGR of 3% during the forecast period.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 62 Herbal/Traditional Products Company Shares 2007-2011
  • Table 63 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • The improved economic conditions enjoyed by lower-income consumers stimulated sales of medicated skin care products in 2011. Historically, minor parasitic infestations and fungal infections had to be ignored by a large number of Brazilians, with limited access to healthcare services and insufficient income to spend on what was perceived to be non-essential medication. This state of affairs began to change in the last decade. The growth experienced during the review period can largely be attributed to rising income levels amongst less affluent consumer segments, socio-economic strata C, D and E, which are now able to afford non-essential health products such as antifungals and antiparasitics. Research conducted by Kantar World Panel indicated that in 2010 non-essential product categories, such as skin creams and lotions, presented 70% participation in purchases carried out by individuals belonging to lower-income groups C, D and E.

SWITCHES

COMPETITIVE LANDSCAPE

  • Hipoglós from Procter & Gamble do Brasil led medicated skin care in 2011 with a 15% value share. The brand enjoys high brand awareness and recognition, combined with high penetration in parapharmacies/drugstores. In spite of the longevity of the brand, with more than 70 years in the Brazilian market, Hipoglós has been able to maintain its popularity amongst younger segments. The annual promotion of Bebê Hipoglós is highly popular with parents, who send pictures of their babies to Procter & Gamble, which chooses which baby will be on Hipoglós advertising campaigns and wins a cash prize of R$10,000.

PROSPECTS

  • Medicated skin care is expected to see a constant value CAGR of 4% in the forecast period.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 68 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 69 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 70 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 71 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 72 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Brazil - Category Analysis

HEADLINES

TRENDS

  • NRT products in Brazil are enjoying growing popularity as a result of government anti-smoking campaigns, combined with restrictive legislation with regard to smoking in public places. As such, more consumers are looking to NRT smoking cessation aids as a way to quit smoking.

SWITCHES

COMPETITIVE LANDSCAPE

  • Nicorette from Johnson & Johnson Industrial led NRT smoking cessation aids in 2011 with a 67% value share. Nicorette benefits from Johnson & Johnson’s wide distribution system and high penetration rate in parapharmacies/drugstores. Nicorette also presents the most extensive product line amongst NRT brands, and as such is able to gain larger shelf-space. In addition, Johnson & Johnson promotes Nicorette through the offer of various services to help those who want to stop smoking. Parallel to World No Tobacco Day Johnson & Johnson launched a series of product placements in popular television programmes, as well as at points of sale, with the slogan: “With Nicorette your craving for smoking will turn to smoke”.

PROSPECTS

  • NRT smoking cessation aids is expected to post a constant value CAGR of 9% in the forecast period 2011-2016. NRT lozenges and NRT gum are expected to see the highest growth rates, with CAGRs of 13% and 9% in constant value terms, respectively.

CATEGORY INDICATORS

  • Table 73 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 74 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 75 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 76 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 77 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 78 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Brazil - Category Analysis

HEADLINES

TRENDS

  • During the review period Brazilians became more conscious about their health and wellbeing, and were interested in leading a healthier lifestyle. However, two contradictory trends are underway. On the one hand, people are leading more active and healthier lifestyles and going to the gym regularly. On the other hand, a large number of Brazilians are leading a more sedentary lifestyle, and this is being passed on to their children.

SWITCHES

COMPETITIVE LANDSCAPE

  • Probiótica Laboratórios led sports nutrition with a 31% value share in 2011. Probiótica has been able to build brand awareness through the sponsorship of body building athletes and UFC (Ultimate Fighting Championship) events. In addition, the company has actively worked towards expanding market penetration at the retail level, and increasing shelf-space for Probiótica brands.

PROSPECTS

  • Sports nutrition is expected to see a constant value CAGR of 14% during the forecast five years 2011-2016. Protein products, particularly protein powder , will lead growth, with a 15% constant value CAGR during the forecast period. Amongst non-protein products, aminoacids are expected to become increasingly popular.

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition: Value 2006-2011
  • Table 82 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 83 Sports Nutrition Company Shares 2007-2011
  • Table 84 Sports Nutrition Brand Shares 2008-2011
  • Table 85 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 86 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Brazil - Category Analysis

HEADLINES

TRENDS

  • Results from research conducted by IBGE (Brazilian Institute of Geography and Statistics) show that the Brazilian diet, whilst rich in rice and beans, which contain good nutritional value, is also rich in calories and poor in nutrients. Brazilians’ consumption of fruit and vegetables is below recommended levels, whilst consumption of sugar-added beverages such as juice and soft drinks is above what is recommended in order to maintain a healthy diet.

VITAMINS

DIETARY SUPPLEMENTS

SWITCHES

COMPETITIVE LANDSCAPE

  • Herbalife presented the strongest increase in share in vitamins and dietary supplements in 2011, moving from a 6% value share in 2010 to 8% in 2011. Brazil is the largest market in Latin America for Herbalife, and the company has continually expanded its product portfolio and its direct selling operations. Its vitamins and dietary supplements product line includes items which are presenting growing demand, such as calcium, fibre and omega 3.

PROSPECTS

  • Vitamins and dietary supplements is expected to see a CAGR of 5% in constant value terms over the forecast period. Improved economic conditions, combined with the changing dietary habits of the Brazilian population, provide a positive appraisal for the coming years.

CATEGORY DATA

  • Summary 38 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 87 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 88 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 89 Dietary Supplements by Positioning 2006-2011
  • Table 90 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 91 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 92 Vitamins Brand Shares by Value 2008-2011
  • Table 93 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 94 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Brazil - Category Analysis

HEADLINES

TRENDS

  • Improved economic conditions amongst lower-income groups contributed to sales growth in 2011. Brazilians who struggled with their weight but were previously not able to afford weight management products were now able to purchase such products. Hoping to take a share of the growing demand, manufacturers expanded their product lines in an attempt to gain consumers’ allegiance, as well as retailers’ loyalty.

SWITCHES

COMPETITIVE LANDSCAPE

  • Herbalife International Do Brasil led weight management with a 59% value share in 2011. The company has been successful in the promotion of meal replacement slimming products such as shakes, and benefited from the expansion of direct selling in general. Herbalife has kept up with the market dynamics in Brazil, and expanded its sales force accordingly.

PROSPECTS

  • Weight management is expected to post a constant value CAGR of 4% during the forecast period. Growing concern about obesity indicates positive prospects for weight management products during the forecast period. Concerns about obesity are likely to increase over the coming years. Many children who are currently overweight have acquired habits which will ensure that they remain overweight in the future. The sedentary habits of many people will continue, with the result that increasing numbers will become obese. It is anticipated that during the forecast period obesity in Brazil will continue to grow.

CATEGORY DATA

  • Table 96 Sales of Weight Management: Value 2006-2011
  • Table 97 Sales of Weight Management: % Value Growth 2006-2011
  • Table 98 Weight Management Company Shares 2007-2011
  • Table 99 Weight Management Brand Shares 2008-2011
  • Table 100 Forecast Sales of Weight Management: Value 2011-2016
  • Table 101 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Brazil - Category Analysis

HEADLINES

TRENDS

  • Sticking plasters/adhesive bandages accounted for a 76% share of value sales of wound care products in 2011. Sales growth is contingent upon manufacturers’ ability to stimulate the usage of wound care products, particularly sticking plasters/adhesive bandages. Manufacturers’ attempts to increase product usage focus on convenience for treating minor cuts and scratches, especially those which occur daily with children. As such, new product introductions commonly feature action figures and other characters which are popular amongst children.

SWITCHES

COMPETITIVE LANDSCAPE

  • Band-Aid from Johnson & Johnson Indústria e Comércio led wound care with a 47% value share in 2011. Band-Aid benefits from Johnson & Johnson’s wide distribution system and extensive market penetration. In addition, as a result of the company’s wide product line, Johnson & Johnson is able to negotiate advantageous shelf positions with retailers at points of sale.

PROSPECTS

  • Wound care is expected to see modest growth over the forecast period, with a CAGR of only 1% in constant value terms from 2011 to 2016.

CATEGORY DATA

  • Table 102 Sales of Wound Care by Category: Value 2006-2011
  • Table 103 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 104 Wound Care Company Shares by Value 2007-2011
  • Table 105 Wound Care Brand Shares by Value 2008-2011
  • Table 106 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 107 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Fibre
            • Guarana
            • Noni
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Paediatric Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Paediatric Consumer Health
        • Paediatric Analgesics
          • Paediatric Acetaminophen
          • Paediatric Aspirin
          • Paediatric Combination Products - Analgesics
          • Paediatric Diclofenac
          • Paediatric Dipyrone
          • Paediatric Ibuprofen
          • Paediatric Ketoprofen
          • Paediatric Naproxen
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Paediatric Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Paediatric Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing
    • Smoking population - number of adult smokers
    • Smoking prevalence - % of adult population

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!